Calyxt Inc (NASDAQ:CLXT) – Research analysts at Jefferies Financial Group lowered their FY2019 earnings per share estimates for Calyxt in a note issued to investors on Wednesday, December 4th. Jefferies Financial Group analyst L. Alexander now forecasts that the company will post earnings of ($1.20) per share for the year, down from their previous estimate of ($1.13). Jefferies Financial Group also issued estimates for Calyxt’s Q4 2019 earnings at ($0.39) EPS, Q1 2020 earnings at ($0.28) EPS, Q2 2020 earnings at ($0.28) EPS, Q3 2020 earnings at ($0.27) EPS, FY2020 earnings at ($1.10) EPS, FY2021 earnings at ($0.80) EPS, FY2022 earnings at ($0.54) EPS and FY2023 earnings at $0.05 EPS.
Calyxt (NASDAQ:CLXT) last posted its quarterly earnings data on Wednesday, November 6th. The company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.01). The company had revenue of $2.97 million during the quarter. Calyxt had a negative return on equity of 43.09% and a negative net margin of 1,016.27%.
Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research downgraded shares of Calyxt from a “hold” rating to a “sell” rating in a report on Monday, December 2nd. BidaskClub raised shares of Calyxt from a “strong sell” rating to a “sell” rating in a report on Thursday, September 12th. Finally, BMO Capital Markets reduced their price objective on shares of Calyxt to $15.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. Calyxt presently has a consensus rating of “Hold” and an average price target of $16.50.
CLXT stock opened at $5.56 on Monday. The company has a market capitalization of $177.94 million, a P/E ratio of -6.11 and a beta of 2.27. The company has a 50-day simple moving average of $4.44 and a 200 day simple moving average of $7.79. Calyxt has a fifty-two week low of $3.55 and a fifty-two week high of $19.30. The company has a quick ratio of 11.97, a current ratio of 12.38 and a debt-to-equity ratio of 0.25.
A number of hedge funds and other institutional investors have recently modified their holdings of CLXT. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in Calyxt by 55.7% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 527,782 shares of the company’s stock valued at $6,587,000 after acquiring an additional 188,749 shares during the last quarter. Swiss National Bank acquired a new stake in Calyxt in the 2nd quarter valued at about $228,000. Wells Fargo & Company MN lifted its holdings in Calyxt by 52.3% in the 2nd quarter. Wells Fargo & Company MN now owns 24,679 shares of the company’s stock valued at $309,000 after acquiring an additional 8,475 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Calyxt by 56.5% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 21,848 shares of the company’s stock valued at $273,000 after acquiring an additional 7,887 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in Calyxt by 60.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 34,973 shares of the company’s stock valued at $436,000 after acquiring an additional 13,109 shares during the last quarter. 27.21% of the stock is owned by institutional investors.
Calyxt Company Profile
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.
Recommended Story: Why do company’s buyback their stock?
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.